258 related articles for article (PubMed ID: 32130468)
21. [Construction of the eukaryotic expression vector with IL-2 gene and VP2 gene of PPV and research on immunogenicity].
Cui BA; Wei ZY; Wang XB; Huang KH; Jin XX; Dong ZJ; Zheng LL
Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):425-30. PubMed ID: 16755922
[TBL] [Abstract][Full Text] [Related]
22. Capsid assembly is regulated by amino acid residues asparagine 47 and 48 in the VP2 protein of porcine parvovirus.
Wang J; Liu Y; Chen Y; Zhang T; Wang A; Wei Q; Liu D; Wang F; Zhang G
Vet Microbiol; 2021 Feb; 253():108974. PubMed ID: 33433338
[TBL] [Abstract][Full Text] [Related]
23. Efficient application of a baculovirus-silkworm larvae expression system for obtaining porcine circovirus type 2 virus-like particles for a vaccine.
He Q; Cao Z; Wang P; Lu Q; Zheng H; Sun J
Arch Virol; 2020 Oct; 165(10):2301-2309. PubMed ID: 32757056
[TBL] [Abstract][Full Text] [Related]
24. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
Wu PC; Chen TY; Chi JN; Chien MS; Huang C
J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
[TBL] [Abstract][Full Text] [Related]
25. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of recombinant classic swine fever virus CD8(+) T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by Lactobacillus casei in swine via oral vaccination.
Xu Y; Cui L; Tian C; Zhang G; Huo G; Tang L; Li Y
Clin Vaccine Immunol; 2011 Nov; 18(11):1979-86. PubMed ID: 21940406
[TBL] [Abstract][Full Text] [Related]
27. A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure.
Antonis AF; Bruschke CJ; Rueda P; Maranga L; Casal JI; Vela C; Hilgers LA; Belt PB; Weerdmeester K; Carrondo MJ; Langeveld JP
Vaccine; 2006 Jun; 24(26):5481-90. PubMed ID: 16730104
[TBL] [Abstract][Full Text] [Related]
28. Potent neutralization activity against type O foot-and-mouth disease virus elicited by a conserved type O neutralizing epitope displayed on bovine parvovirus virus-like particles.
Chang J; Zhang Y; Yang D; Jiang Z; Wang F; Yu L
J Gen Virol; 2019 Feb; 100(2):187-198. PubMed ID: 30547855
[TBL] [Abstract][Full Text] [Related]
29. Self-Assembly of Porcine Parvovirus Virus-like Particles and Their Application in Serological Assay.
Gao Y; Wang H; Wang S; Sun M; Fang Z; Liu X; Cai X; Tu Y
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016450
[TBL] [Abstract][Full Text] [Related]
30. Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2.
Li Y; Wang Y; Cheng J; Zhou X; Lu H; Zhang X; Xia X; Sun H
Virol J; 2020 Jun; 17(1):72. PubMed ID: 32517704
[TBL] [Abstract][Full Text] [Related]
31. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of virus-like particles containing modified goose parvovirus VP2 protein.
Chen Z; Li C; Zhu Y; Wang B; Meng C; Liu G
Virus Res; 2012 Oct; 169(1):306-9. PubMed ID: 22940567
[TBL] [Abstract][Full Text] [Related]
33. Investigation of Kluyveromyces marxianus as a novel host for large-scale production of porcine parvovirus virus-like particles.
Yang D; Chen L; Duan J; Yu Y; Zhou J; Lu H
Microb Cell Fact; 2021 Jan; 20(1):24. PubMed ID: 33494762
[TBL] [Abstract][Full Text] [Related]
34. Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles.
Rueda P; Fominaya J; Langeveld JP; Bruschke C; Vela C; Casal JI
Vaccine; 2000 Nov; 19(7-8):726-34. PubMed ID: 11115693
[TBL] [Abstract][Full Text] [Related]
35. Development and evaluation of the rVP-ELISA for detection of antibodies against porcine parvovirus.
Kong M; Peng Y; Cui Y; Chang T; Wang X; Liu Z; Liu Y; Zhu Y; Luo Y; Tang Q; Feng L; Cui S
J Virol Methods; 2014 Sep; 206():115-8. PubMed ID: 24945904
[TBL] [Abstract][Full Text] [Related]
36. Production and purification of VP2 protein of porcine parvovirus expressed in an insect-baculovirus cell system.
Zhou H; Yao G; Cui S
Virol J; 2010 Dec; 7():366. PubMed ID: 21143963
[TBL] [Abstract][Full Text] [Related]
37. Porcine parvovirus VP1/VP2 on a time series epitope mapping: exploring the effects of high hydrostatic pressure on the immune recognition of antigens.
de Souza AR; Yamin M; Gava D; Zanella JRC; Gatti MSV; Bonafe CFS; de Lima Neto DF
Virol J; 2019 Jun; 16(1):75. PubMed ID: 31159841
[TBL] [Abstract][Full Text] [Related]
38. Expression of porcine parvovirus VP2 gene requires codon optimized E. coli cells.
Qi T; Cui S
Virus Genes; 2009 Oct; 39(2):217-22. PubMed ID: 19543964
[TBL] [Abstract][Full Text] [Related]
39. Identification of a dominant linear epitope on the VP2 capsid protein of porcine parvovirus and characterization of two monoclonal antibodies with neutralizing abilities.
Liu Y; Wang J; Chen Y; Wang A; Wei Q; Yang S; Feng H; Chai S; Liu D; Zhang G
Int J Biol Macromol; 2020 Nov; 163():2013-2022. PubMed ID: 32931829
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the immune responses induced by oral immunization of mice with Lactobacillus casei-expressing porcine parvovirus VP2 and VP2 fused to Escherichia coli heat-labile enterotoxin B subunit protein.
Liu D; Wang X; Ge J; Liu S; Li Y
Comp Immunol Microbiol Infect Dis; 2011 Jan; 34(1):73-81. PubMed ID: 20226529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
